Intratumoral steroidogenesis in castration-resistant prostate cancer: a target for therapy

Development of castration-resistant prostate cancer (CRPC) in a low androgen environment, arising from androgen deprivation therapy (ADT), is a major problem in patients with advanced prostate cancer (PCa). Several mechanisms have been hypothesized to explain the progression of PCa to CRPC during AD...

Full description

Bibliographic Details
Main Authors: Inna Armandari, Agus Rizal Hamid, Gerald Verhaegh, Jack Schalken
Format: Article
Language:English
Published: Elsevier 2014-09-01
Series:Prostate International
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2287888215300568